Mirae Asset Global Investments Co., Ltd. Pear Therapeutics, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 10, 2022	SELL	$0.13 - $2.27 $1,384 - $24,177	-10,651 Reduced 5.11%	197,854 $404,000
Q2 2022 Aug 15, 2022	BUY	$1.54 - $6.48 $321,097 - $1.35 Million	208,505 New	208,505 $321,000

23M

Ticker PEAR
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 138,768,992
Market Cap $1.39M
Description
Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a softwa...

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.